HomeAwards Best Poster Award

Best Poster Award

These awards are selected by the Young Urologic Oncologists Committee at the meeting. The Committee selects the three best posters presented at the meeting by a resident or fellow. The awardees are recognized at the meeting and presented a plaque.


2016

December Meeting 2016 Fellow/Resident Poster Award Winners
Wednesday, November 30, 2016

1st
Ryan Hutchinson, MD: Whole Exome Assessment of Grade Progression in Low-Grade Non-Invasive Bladder Tumors

2nd
Kymora Scotland, MD, PhD: A Novel Method for Harvesting and Culture of Ex Vivo Human Prostate Tissue

3rd
Ryan Steinberg, MD: BCG Strain has No Significant Effect on Recurrence-Free Survival When Used Intravesically with Interferon-Alpha2B for Non-Muscle Invasive Bladder Cancer

Thursday, December 1, 2016

1st
Max Kates, MD: Intravesical BCG Induces CD4+ Expansion but not Differentiation in a Clinically Relevant Immune Model of Bladder Cancer

2nd
Vidit Sharma, MD: Tumor draining Lymph Nodes in Prostate Cancer Harbor Immune Suppressor Cells That May Impair Tumor-Reactive T Cells

3rd
Amy N. Luckenbaugh, MD: Impact of Accountable Care Organizations on Prostate Specific Antigen (PSA) Testing and Prostate Biopsy

2015

December Meeting 2015 Fellow/Resident Poster Award Winners
Wednesday, December 2nd Winners

1st
Michael Gorin, MD (#46) Prospective Evaluation of 99mtc-Sestamibi Spect/Ct for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors

2nd
Suzanne Stewart-Merrill, MD (#17) Oncologic Surveillance Following Radical Cystectomy: An Individualized Risk-Based Approach

3rd
Roland Seiler, MD (#22) Targeting the Glycome in Cisplatin-Resistant Bladder Cancer with a Naturally Occurring Parasite-Host Anchor Protein

Thursday, December 3rd Winners

1st
Hung-Jui Tan, MD, MSHPM (#145) Patient Disability and Treatment Variation Among Older Adults with Kidney Cancer

2nd
Eugene Pietzak, MD (#134) Prospective Identification of Genomic Alterations in Muscle-Invasive Bladder Cancer (Mibc) and Metastatic Urothelial Carcinoma (Uc) Using a Next-Generation Sequencing (Ngs) Assay

3rd
Divya Ajay, MD, MPH (#180) Primary Prevention of Penile Cancer: Is HPV Vaccination a Good Idea?

2014

December Meeting 2014 Fellow/Resident Poster Award Winners
Wednesday, December 3rd Winners

Vladimir Valera, MD, PhD (#23) Preclinical Model of Dual-Specific, MTOR Complex 1 (TORC1) and MTOR Complex 2 (TORC2) Inhibitors for Bladder Cancer Treatment

Suzanne Steward, MD (#42) Oncologic Surveillance Following Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach

Zachary Klaassen, MD (#1) Predictors of Metastatic Disease at Diagnosis in Patients with Urothelial Carcinoma of the Bladder

Thursday, December 4th Winners

Mark Ball, MD (#150) Grade Heterogeneity in Small Renal Masses: Potential Implications for Renal Mass Biopsy

Massimiliano Spaliviero, MD (#186) Precise Intraoperative Detection of Prostate Cancer and Complete Resection of Microscopic Residual Disease with Novel Serrs Nanostars

Xiaosong Meng, MD, PhD(#179) Comparison of MR-Targeted Prostate Biopsy by MRI-US Fusion Versus Systematic Prostate Biopsy in Patients with Pre-Biopsy 3T Multi-Parametric MRI: Single Institution Experience in 615 Patients

2013

December Meeting 2013 Fellow/Resident Poster Award Winners:
Thursday, December 5th Winners

Christopher Barbieri, PhD, MD (#178) SPOP Mutations In Prostate Cancer Across Ethnically and Geographically Diverse Patient Cohorts (New York-Presbyterian Hospital)

Adam Weiner, BS (#67) Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications For Use of Active Surveillance (2004-2010)

Daniel Yelfimov, MD (#88) Imaging of Prostatic Anatomy in Patient with Known Prostate Cancer Using Magnetic Resonance Elastography: A Feasibility Study

Friday, December 6th Winners

Jeffrey Tomaszewski, MD (#110) Treatment Delay for Muscle Invasive Bladder Cancer: Implications for Regionalization of Care(Fox Chase Cancer Center)

Paul R. Womble, MD (#184) Infection-Related Hospitilzations after Prostate Biopsy in a State-Wide Quality Improvement Collaborative (University of Michigan, Ann Arbor)

Michael A. Liss, MD (#175) Mortality Benefit of Screening Men with a Family History of Prostate Cancer as a Surrogate for High Genetic Risk in the PLCO Trial (UC San Diego)

2012

December Meeting 2012 Fellow/Resident Poster Award Winners:
Thursday, November 29th Winners

Mark Preston, MD (#99) The Association Between Finasteride Use and High-Grade or Lethal Prostate Cancer (Dana Farber Cancer Center)

Joshua Logan, MD (#56) An Inhibitor of Cyclin-Dependent Kinase 4/6, Demonstrates, Differential Inhibition of Proliferation in RCC at Nanomolar Concentrations and Molecular Markers Predict for Sensitivity (UCLA)

Christopher Anderson, MD (#31) Women are Less Likely To Receive Evidence-Based Processes of Care for the Treatment of Bladder cancer as Compared to Men (Vanderbilt University)

Friday, November 30th Winners

Matthew Wszolek, MD (#131) Microrna 200 Family Members Predict Prognosis in Muscle Invasive Urothelial Carcinoma of the Bladder (MD Anderson)

Michael Large, MD (#119) The Impact of Running Versus Interrupted Ureteroenteric Anastomosis on Rate of Ureteral Structure in Radical Cystectomy (University of Chicago)

Lih-Ming Wong (#178) Active Surveillance: Predictors of Pathological Re-Classification on the Second Prostatic Biopsy

2011

December Meeting 2011 Fellow/Resident Poster Award Winners:
Thursday, December 1st Winners

Todd M. Morgan, MD (#40) Novel Renal Cell Carcinoma Biomarker Identification from Urinary Exosomes (Vanderbilt University)

Karim Chamie, MD (#11) The Impact of Accurate Staging on Bladder Cancer Survival: A Process-Outcomes Link (UCLA)

David Margel, MD (#67) Impact of Prostate MRI on Disease Reclassiciation Among Active Surveillance Candidates—A Prospective Cohort Study

Friday, December 2nd Winners

Robert Chan, MD (#183) Prostate Cancer Immunotherapy Using Bi-Specific Tumor-Reactive T Cells

Christopher Anderson, MD (#166) Trends in Usage of Radical Prostatectomy in the United States: 2000 – 2008

2010

December Meeting 2010 Fellow/Resident Poster Award Winners:
Thursday, December 9th Winners

Alexandra Colquhoun, MD (#45): Utilizing Metformin to Enhance the Efficacy of Androgen Deprivation Therapy in the Treatment of Prostate Cancer (Sunnybrook Health Sciences Centre)

Neema Navai, MD (#61): Genetic Variants in the Vitamin D Pathway Genes Predict Recurrence Risk for Non-muscle Invasive Bladder Cancer (MD Anderson)

Dan Lewinshtein, MD (#99): Risk of Specific Secondary Malignancy in Testicular Cancer Patients Exposed to Radiation (Virginia Mason Medical Center)

Friday, December 10th Winners

David Margel, MD (#104): Stress Proteins and Cytokines May Serve as Urinary Biomarkers for Diagnosis and Staging of Bladder Cancer (Princess Margaret Hospital)

Shaheen R. Alanee, MD (#171): How Does Level I Evidence Affect Treatment Trends of EBRT+AST Combination Therapy for Prostate Cancer? (University of Minnesota)

Kirk A. Keegan II, MD (#191): Financial Implications of Active Surveillance for Prostate Cancer: the Impact of Delayed Active Treatment Versus Initial Treatment (Vanderbilt University) 

2009

December Meeting 2009 Fellow/Resident Poster Award Winners:
Thursday, December 3rd Winners

Genevieve Nadeau (#78): Copy number of sex-steroid metabolizing genes as biomarkers of prostate cancer (Laval University)

Melanie Ketchandji (#74): Disseminated prostate cancer CTCs: best marker (UW, Seattle)

William Lowrance (#5): Comparative effectiveness of surgical treatments for PCa (MSKCC) 

Friday, December 4th Winners

Danil Makarov (#109): Inappropriate imaging use for PCa staging (Yale) 

E. Jason Abel (#154): Biopsy of metastatic sites of RCC (MD Anderson)

Sultan Alkhateeb (#192): Prognosis of primary or recurrent T1G3 TCC post BCG (Toronto)

2008

December Meeting 2008 Fellow/Resident Poster Award Winners:
Thursday, December 4th Poster Session I Winners

1st
Jay Bakul Shah, MD Anderson Cancer Center
Poster 7 – The SRC inhibitor AZD350 induces growth inhibition and migratory arrest of human bladder cancer cell lines

2nd
JoseAntonio Karam, University of Texas Southwestern Medical Center
Poster 1 – Uoprregulation of trag3 (taxol resistance associated gene3) is associated with advanced bladder cancer (BCA)

3rd
Robert Scott Svatek, MD Anderson Cancer Center
Poster 14 – The transcription repressor, ZEB1, regulates epithelial to mesenchmal transition in bladder cancer

Friday, December 5th Poster Session Winners

1st
Vitaly Margulis, MD, MD Anderson Cancer Center
Poster 187 – Multi-institutional validation of the predictive value of KI-67 labeling index patients with urinary bladder cancer

2nd
Vincent Fradet, MD, UCSF, San Francisco
Poster 103 – Dietary Omega-3 Fatty Acids, COX-2 generic variation, and aggressive prostate cancer risk

3rd
Matthew Cooperberg, MD, University of California
Poster 170 – National trends in treatment of stage irenal cell carcinoma

2007

December Meeting 2007 Fellow/Resident Poster Award Winners:

R. Houston Thompson, MD; Memorial Sloan Kettering Cancer Center
B7-H3 AND B7X ARE HIGHLY EXPRESSED IN HUMAN PROSTATE CANCER AND ASSOCIATED WITH DISEASE SPREAD AND POOR OUTCOME
R. Houston Thompson, MD; Xingxing Zang, PhD; Hikmat Al-Ahamadie, MD; Angel Serio, MS; Victor Reuter, MD; James Eastham, MD; Peter Scardino, MD; Padmanee Sharma, MD and James Allison, PhD (Presented by: R. Houston Thompson)

Boris Hadaschick, MD; The Prostate Centre at VGH
INTRAVESICAL THERAPY OF HIGH GRADE BLADDER CANCER WITH HTI-286
Boris Hadaschik, MD; Hans Adomat; Ladan Fazli, MD; Martin Gleave, MD and Alan So, MD (Presented by: Boris Hadaschik)

Shahrokh Shariot, MD; UT Southwestern Medical School
MULTIPLE BIO-MARKERS FOR THE PREDICTION OF BLADDER CANCER RECURRENCE AND MORTALITY
Shahrokh Shariat, MD; Pierre I. Karakiewicz, MD; Raheela Ashfaq, MD; Seth P. Lerner, MD; Ganesh S. Palapattu, MD; Richard J. Cote, MD; Arthur I. Sagalowsky, MD and Yair Lotan, MD (Presented by: Shahrokh Shariat) 

2006

December Meeting 2006 Fellow/Resident Poster Award Winners:

Stephen Boorjian, MD; Mayo Clinic
THE IMPACT OF GLEASON SCORE ON THE PREDICTIVE VALUE OF PSA DOUBLING TIME
Stephen Boorjian, MD; Sameer Siddiqui, MD; Brant Inman, MD; Jeffrey Slezak; R. Jeffrey Karnes, MD; Michael Blute, MD and Bradley Leibovich, MD (Presented By: Stephen Boorjian, MD)

Ofer Yossepowitch, MD; Memorial Sloan Kettering Cancer Center
RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED HIGH-RISK PROSTATE CANCER: CRITICAL ANALYSIS OF RISK-ASSESSMENT METHODS
Ofer Yossepowitch, MD; Scott Eggener, MD; Fernando Bianco, MD; Brett Carver, MD; Angel Serio, MD; Peter Scardino, MD and James Eastham, MD (Presented By: Ofer Yossepowitch, MD)

Todd Morgan, MD; University of Washington
DETECTION AND ISOLATION OF DISSEMINATED TUMOR CELLS BY ENRICHMENT IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY
Todd Morgan, MD; Daniel Lin, MD; William Ellis, MD; Ian Gallaher, BA; Marty Kinnunen, BA; Bryce Lakely, BA; Paul Lange, MD and Robert Vessella, PhD (Presented By: Todd Morgan, MD) 

2005

December Meeting 2005 Fellow/Resident Poster Award Winners:

R. Houston Thompson, MD, Mayo Clinic
COMPLICATIONS FROM CONTEMPORARY OPEN NEPHRON-SPARING SURGERY
R. Houston Thompson, MD, Bradley Leibovich, MD, Christine Lohse, MS, Horst Zincke, MD PhD and Michael Blute, MD (Presented By: R. Houston Thompson, MD)

Bungo Furusato, MD, PhD, Armed Forces Institute for Pathology
GENE EXPRESSION SIGNATURES IN BENIGN AND MALIGNANT EPITHELIAL CELLS FROM FORMALIN-FIXED PARAFFIN-EMBEDDED (FPPE) TISSUES OF PROSTATE CANCER PATIENTS
Bungo Furusato, MD, PhD, Gyorgy Petrovics, PhD, Vasantha Srikantan, DVM, PhD, Syed Shaheduzzaman, PhD, Lakshmi Ravindranath, BS, Martin E Nau, PhD, Maryanne Vahey, PhD, David G McLeod, MD, Shiv Srivastava, PhD and Isabell A Sesterhenn, MD (Presented By: Bungo Furusato, MD, PhD)

Paul Crispen, MD, Fox Chase Cancer Center
TREATMENT WITH TNF-A AND TPEN DECREASES NF-KB ACTIVITY AND INDUCES APOPTOSIS IN PC-3 CELLS
Paul Crispen, MD, Konstantin Golovine, MD PhD, Peter Makhov, MD PhD, Alan Pollack, MD PhD, Eric Horwitz, MD, Richard Greenberg, MD, Robert Uzzo, MD and Vladimir Kolenko, MD PhD (Presented By: Paul Crispen, MD)